ETIOLOGY OF AIDS: VIROLOGY, MOLECULAR BIOLOGY, AND EVOLUTION OF HUMAN IMMUNODEFICIENCY VIRUSES NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


ETIOLOGY OF AIDS: VIROLOGY, MOLECULAR BIOLOGY, AND EVOLUTION OF HUMAN IMMUNODEFICIENCY VIRUSES

AIDS: Etiology, Diagnosis, Treatment, and Prevention. Second Edition. DeVita VT Jr et al, eds. Philadelphia, Lippincott, p. 11-31, 1988.. Unique Identifier : AIDSLINE ICDB/89650898
Shaw GM; Wong-Staal F; Gallo RC; Univ. of Alabama, Birmingham, AL


Abstract: Remarkable progress has been made since the first description of AIDS in 1981 in elucidating the causative agent, defining its biologic and genetic properties, and understanding its evolutionary relationship to other retroviruses. This chapter describes progress and emerging directions of the basic research likely to be important in developing a better understanding of HIV disease and effective treatment and preventive measures. Topics discussed include the history of human retrovirology, discovery of the AIDS virus, overview of HIV-1 biology, molecular structure and function of HIV-1, characteristics of HIV-2, and evolution of human immunodeficiency viruses. HIV-1 utilizes complex strategies for regulating viral expression. These operate at the level of transcription, mRNA processing, protein synthesis, and virus maturation. Because the R and 3' orf genes are highly conserved in evolutionarily divergent viruses, they may be important in the biology of HIV in vivo, although their specific functions are currently unknown. One of the most striking properties of the HIV-1 genome is the extent of variability that exists among independent virus isolates. The genome of HIV-1 is highly plastic in relation to such important functions as cell tropism, virulence, and antigenicity. The observation that HIV-1 'isolates' generally consist of complex mixtures of genotypically distinct viruses supports the general concept of RNA viruses as 'quasi-species.' A T-lymphotropic human virus (HN-2), related to the Simian immunodeficiency virus (SIV), has been identified in studies of West African populations. There are reports that the HIV-2 group of viruses, although clearly a causative agent of some cases of fatal immunodeficiency, may be less pathogenic in some populations than HIV-1. There is, however, an increasing number of reports identifying HIV-2 viruses as the cause of fatal immunodeficiency in West Africa and other countries. Because HIV-2 and simian immunodeficiency virus (mac) are nearly equally divergent from HIV-1 and more similar to each other in genomic organization, HIV-2 and SIV (mac) may have evolved from a common ancestor, which in turn had common origins with HIV-1. (156 Refs)
Keywords: Acquired Immunodeficiency Syndrome/GENETICS/*MICROBIOLOGY Amino Acid Sequence Cloning, Molecular Cytopathogenic Effect, Viral DNA Restriction Enzymes/GENETICS Gene Expression Regulation Genes, Viral Human HIV Antigens/GENETICS HIV-1/*GENETICS HIV-2/*GENETICS Molecular Sequence Data Receptors, Virus/GENETICS Retroviridae Proteins/GENETICS RNA, Messenger/GENETICS Viral Envelope Proteins/GENETICS Virus Replication MONOGRAPH REVIEW REVIEW, TUTORIAL

KWDacquiredimmunodeficiencysyndrome/genetics/KWDmicrobiologyaminoacidsequencecloning,molecularcytopathogeniceffect,viraldnarestrictionenzymes/geneticsgeneexpressionregulationgenes,viralhumanhivantigens/geneticshiv-1/KWDgeneticshiv-2/KWDgeneticsmolecularsequencedatareceptors,virus/geneticsretroviridaeproteins/geneticsrna,messenger/geneticsviralenvelopeproteins/geneticsvirusreplicationmonographreviewreview,tutorial
890630
M8960615


Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .